Language

English

Publication Date

11-5-2025

Journal

Communications Biology

DOI

10.1038/s42003-025-09050-3

PMID

41193733

PMCID

PMC12589595

PubMedCentral® Posted Date

11-5-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Prior research shows that Akt-dependent phosphorylation of TopBP1 in S phase results in the switch of TopBP1/Treslin binding to TopBP1/E2F1 binding, which is important to prevent replication re-initiation in late S and G2 phases. Here, we demonstrate that contact, but not conformational, mutant p53 can override this switch by binding to both TopBP1 and Treslin, thereby facilitating persistent TopBP1/Treslin interaction in late S and G2 phases, which ultimately leads to over-firing of replication initiation. This increases micronuclei formation, which is further enhanced by genotoxic stressors such as doxorubicin, PARP inhibitors, or ATR inhibitors. Consequently, contact mutant p53 increases the sensitivity of cancer cells to a TopBP1-BRCT7/8 inhibitor combined with PARP or ATR inhibitors. Importantly, contact mutant p53 induces micronuclei formation and MRE11 expression, thereby activating cGAS-STING pathway and enhancing response to immune checkpoint inhibition. This finding is validated in murine mammary tumor allografts and further corroborated by clinical data.

Keywords

Tumor Suppressor Protein p53, Humans, Nucleotidyltransferases, Animals, Membrane Proteins, Mice, Immune Checkpoint Inhibitors, Mutation, Cell Line, Tumor, Female, DNA Replication, Carrier Proteins, DNA-Binding Proteins, Nuclear Proteins

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.